Background
==========

The benefits from treatment with antivenom sera are indubitable. However, the mechanism for toxin neutralization has not been completely elucidated. A mixture of anti-bothropic and anti-crotalic horse antivenom has been reported to be more effective in neutralizing the effects of *B. jararacussu*snake venom than anti-bothropic antivenom alone. This study determined which regions in the three PLA~2~s from *B.jararacussu*snake venom are bound by antibodies in tetravalent anti-bothropic and monovalent anti-crotalic commercial horse antivenom.

Methods
=======

The epitopes recognized by therapeutic horse antivenom sera in the three major PLA~2~s present in the venom of *B. jararacussu* , BthTX-I, BthTX-II and BthA-I, were mapped using the parallel Spot-synthesis strategy. Two peptide libraries were designed to more precisely define the epitopes recognized by anti-bothropic and/or anti-crotalic horse antivenom. Each consisted of 69 peptide sequences of fourteen amino acids each that overlapped by nine amino acids and covered the entire protein sequences of the three PLA~2~s. The oligomeric structure of PLA~2S~proteins were solved by X-ray crystallography and are available in the protein data bank. The sequences of fifty PLA~2~s were selected and grouped into three sub-groups. Shared amino acids sequence from the 12 epitopes recognized by the reaction between the *B. jararacussu*PLA~2~s and anti-crotalic/anti-bothropic horse antivenom were analyzed by a multiple sequence alignment.

Results and conclusions
=======================

Mapping experiments of BthTX-I, BthTX-II and BthA-I using two small libraries of 69 peptides each revealed six major IgG-binding epitopes that were recognized by both anti-bothropic and anti-crotalic horse antivenom. Two epitopes in BthTX-I were only recognized by the anti-bothropic horse antivenom, while anti-crotalic horse antivenom recognized four unique epitopes across the three PLA~2~s. Our studies suggest that the harmful activities of the PLA~2~s present in the venom of *B. jararacussu*are neutralized by the combinatorial treatment with both antivenom sera through their complementary binding sites, which provides a wide coverage on the PLA~2~s. In conclusion, the peptide arrays formed directly onto cellulose membranes allowed the identification of the major antigenic determinants in the three most important PLA~2~s (BthTX-I, BthTX-II and BthA-I) isolated from *B. jararacussu*snake venom recognized by commercial anti-bothropic and anti-crotalic horse antivenom. The cross-reactive epitopes located in the Lys49-PLA~2~, the major protein of this venom, recognized two specific epitopes located in a region of the enzyme responsible for the myotoxic action, which contributes to the deleterious effects of snake venom. In addition, the ability of the anti-crotalic horse antivenom to neutralize the anticoagulant activity was most likely associated with the acidic Asp49-PLA~2~. This study provides proof that the mixture of anti-crotalic and anti-bothropic horse antivenom is qualitatively more effective in neutralizing the effects unleashed of *B. jararacussu*snakebite. Regions recognized by the protective antivenom sera are prime candidates for improved venom cocktails or a chimeric protein encoding the multiple epitopes to immunize animals as well as for designing future synthetic vaccines.
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